Escalon Medical Corp (ESMC) stock
ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –
Escalon Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Escalon Medical's revenue for the twelve months ending Jun 30, 2026 was $12.74M, up 5.7% year over year. For fiscal 2026 it was $12.74M, up 5.7% from the year before. Over ten years it grew 1.0% a year on average. The highest annual figure on record is $25.58M in fiscal 2011.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $12.74M | +5.7% |
| FY2025 | Jun 30, 2025 | $12.05M | +0.5% |
| FY2024 | Jun 30, 2024 | $11.98M | -1.6% |
| FY2023 | Jun 30, 2023 | $12.18M | +13.8% |
| FY2022 | Jun 30, 2022 | $10.70M | +2.2% |
| FY2021 | Jun 30, 2021 | $10.47M | +11.4% |
| FY2020 | Jun 30, 2020 | $9.40M | -2.4% |
| FY2019 | Jun 30, 2019 | $9.63M | -15.6% |
| FY2018 | Jun 30, 2018 | $11.40M | +1.5% |
| FY2017 | Jun 30, 2017 | $11.23M | -3.0% |
| FY2016 | Jun 30, 2016 | $11.58M | -11.9% |
| FY2015 | Jun 30, 2015 | $13.14M | +6.3% |
| FY2014 | Jun 30, 2014 | $12.35M | +7.5% |
| FY2013 | Jun 30, 2013 | $11.50M | +0.3% |
| FY2012 | Jun 30, 2012 | $11.46M | -55.2% |
| FY2011 | Jun 30, 2011 | $25.58M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $3.86M | +50.2% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $2.61M | -24.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $3.59M | +11.5% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $2.68M | -3.8% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $2.57M | -26.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $3.47M | +28.9% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $3.22M | +12.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $2.78M | -5.6% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $3.47M | +10.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $2.70M | -21.5% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $2.87M | -4.5% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $2.95M | +13.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $3.14M | +7.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $3.43M | +42.1% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $3.01M | +11.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $2.60M | -2.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $2.91M | +2.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $2.42M | +3.9% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $2.70M | -6.8% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $2.68M | +10.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $2.83M | +40.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $2.32M | -1.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $2.90M | +5.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $2.41M | +5.5% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.01M | -11.7% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $2.36M | -11.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $2.74M | +13.3% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $2.29M | +1.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $2.28M | -17.2% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $2.67M | +1.3% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $2.42M | -28.5% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $2.26M | -14.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $2.75M | -4.9% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $2.64M | -7.4% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $3.38M | +7.0% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $2.63M | +12.8% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $2.89M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $2.85M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $3.16M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $2.33M | – |
See a number that looks wrong?